NASHUA, N.H., Nov. 14 /PRNewswire-FirstCall/ -- iCAD, Inc. , an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced it will unveil its latest CAD innovations for more than 60,000 industry experts attending the Radiological Society of North America (RSNA)'s Annual Meeting in Chicago, November 25-30 (booth #3507).
At the meeting, iCAD will provide demonstrations of its SecondLook(R) suite of products, including its most recent developments that showcase SecondLook Digital's unique compatibility with industry leading Full-Field Digital Mammography (FFDM) and Computed Radiography (CR) solutions. iCAD's latest innovations deliver powerful performance improvements increasing the radiologist's confidence of findings while enhancing workflow. iCAD will also feature CAD applications for tomosynthesis and CT colonography that are currently under development.
"iCAD sees a wide range of application opportunities for CAD, and the RSNA is the ideal venue to share our vision for the direction of the technology with key industry leaders. Our expanded and enhanced mammography solutions coupled with new development areas, such as CT colonography, will help drive the future of CAD," said Ken Ferry, Chief Executive Officer of iCAD, Inc. "As facilities look to expand their CAD offerings, iCAD's proven interoperability makes it an ideal choice for both large and small scale implementations."
iCAD offers high-performance CAD solutions for both digital and film-based mammography systems. iCAD's systems are based on sophisticated algorithms that analyze the data; automatically identifying and marking suspicious regions in the images. The result is earlier detection of hard-to-find cancers, improved workflow for radiologists, and higher quality patient care.
Additionally, iCAD is developing CAD solutions for use with virtual colonoscopy to improve the detection of colonic polyps. By focusing on superior identification capabilities, iCAD's system for virtual colonoscopy is designed to assist in improving accuracy and workflow during the reading process.
About iCAD, Inc.
iCAD, Inc. is an industry-leading provider of Computer- Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by over one thousand women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit www.icadmed.com.
ddeptula@icadmed.com
For iCAD Investor Relations, contact Anne Marie Fields of Lippert/Heilshorn &
Associates at 212-838-3777 x6604 or via email at icad@lhai.comicad@schwartz-pr.com
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:
Certain statements contained in this News Release constitute "forward- looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the risks of uncertainty of patent protection, the impact of supply and manufacturing constraints or difficulties, product market acceptance, possible technological obsolescence, increased competition, customer concentration and other risks detailed in the Company's filings with the Securities and Exchange Commission. The words "believe", "demonstrate", "intend", "expect", "estimate", "anticipate", "likely", and similar expressions identify forward- looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release.
CONTACT: Darlene Deptula-Hicks, EVP and CFO of iCAD, Inc., +1-603-882-5200
x7944, ddeptula@icadmed.com, or Investor Relations, Anne Marie Fields of
Lippert, Heilshorn & Associates, +1-212-838-3777 x6604, icad@lhai.com, or
Public Relations, Wendy Ryan of Schwartz Communications, +1-781-684-0770,
icad@schwartz-pr.com, both for iCAD, Inc.
Web site: http://www.icadmed.com/
